Published in Naunyn Schmiedebergs Arch Exp Pathol Pharmakol on January 01, 1968
Carcinogenic effects of N-nitroso-3-(substituted phenylimino)-indolin-2-one derivatives. J Pharm Bioallied Sci (2012) 0.75
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer (1996) 1.84
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer (1979) 1.49
Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissue. Am J Obstet Gynecol (1992) 1.43
P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer (1989) 1.39
Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog Lipid Res (2004) 1.34
Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol (2001) 1.18
Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer (1998) 1.18
Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev (1982) 1.16
Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Cancer Res (1985) 1.15
Rat liver and hepatoma polysome-membrane interaction in vitro. Biochem Biophys Res Commun (1966) 1.13
Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer (1999) 1.10
Tumor initiation and promotion. Int Rev Exp Pathol (1978) 1.10
Depressive action of serum of partially hepatectomized rats on tumour cells in vitro. Eur J Cancer (1967) 1.08
Tumour induction in the rodent Mastomys natalensis by activation of endogenous papilloma virus genomes. Nature (1984) 1.05
DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry (1985) 1.04
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol (1993) 1.02
Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. Anticancer Res (2000) 1.02
Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer (1985) 1.00
Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res (1990) 0.98
Stimulation of choline incorporation in cell cultures by phorbol derivatives and its correlation with their irritant and tumor-promoting activity. Cancer Res (1979) 0.97
[Selective tumour chemotherapy using oncobiograms (author's transl)]. Dtsch Med Wochenschr (1974) 0.97
Phorbol esters as a tool in cell research? Eur J Cancer (1972) 0.96
Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res (1997) 0.95
Gastric carcinoma metastatic to the site of a congenital melanocytic nevus. J Am Acad Dermatol (1993) 0.93
Growth of human bronchial carcinomas in nude mice. Br J Cancer (1985) 0.93
Human tumor xenografts as model for drug testing. Cancer Metastasis Rev (1988) 0.93
[Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions]. Schweiz Med Wochenschr (1975) 0.93
Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res (2001) 0.92
[Quick method for sensitivity tests of malignant tumors against antineoplastic agents]. Klin Wochenschr (1970) 0.90
Detection of drug resistance and P-glycoprotein in human renal cell carcinomas. Eur Urol (1990) 0.90
Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis (1993) 0.90
Incorporation of 131 iododeoxyuridine into the DNA of tumour-bearing rats after partial synchronization as a tool in scintigraphic tumour localization. Nucl Med (Stuttg) (1974) 0.89
Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas. Int J Oncol (1995) 0.89
Clinical correlates of in vitro effect of adriamycin on advanced lung carcinoma. Klin Wochenschr (1976) 0.88
Smoking-related increase of O6-methylguanine-DNA methyltransferase expression in human lung carcinomas. Carcinogenesis (1998) 0.87
Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res (2000) 0.87
Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents. Behring Inst Mitt (1984) 0.86
Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol (1999) 0.85
Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res (1997) 0.85
Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin. Anticancer Drugs (1997) 0.85
Isopycnic density-gradient centrifugation: a separation parameter which improves flow cytometric measurements on heterogeneous tumors. Cytometry (1983) 0.84
[Incorporation of a 131-iodine-deoxycytidine monophosphate protamine complex into the DNA of tumor-bearing rats following partial synchronization with hydroxyurea]. Nucl Med (Stuttg) (1975) 0.84
Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer (1996) 0.84
Kinetic complexity of nuclear poly(A)-containing RNA in normal and regenerating rat liver. Eur J Biochem (1979) 0.84
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.84
O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int J Cancer (1998) 0.84
Occurrence of a multidrug-resistant phenotype in human lung xenografts. Br J Cancer (1987) 0.83
Deterioration of spermatozoal plasma membrane is associated with an increase of sperm lyso-phosphatidylcholines. Andrologia (2002) 0.83
CsCl as an auxiliary reagent for the analysis of phosphatidylcholine mixtures by matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS). Chem Phys Lipids (2001) 0.82
Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.82
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.82
Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms. Cancer Lett (1993) 0.82
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamil. Chemotherapy (1991) 0.82
[Individual chemotherapy of solid tumors]. Med Welt (1976) 0.82
Phorbol ester stimulates choline incorporation. Naturwissenschaften (1971) 0.81
Cocarcinogenic croton oil factor A1 stimulates lipid synthesis in cell cultures. Experientia (1971) 0.81
Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis (1995) 0.81
Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo. Radiat Res (1991) 0.80
P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia. Br J Cancer (1994) 0.80
Lectin mediates homing of sialidase-treated erythrocytes of the liver as revealed by scintigraphy. Hoppe Seylers Z Physiol Chem (1981) 0.80
Differently complex oligosaccharides can be easily identified by matrix-assisted laser desorption and ionization time-of-flight mass spectrometry directly from a standard thin-layer chromatography plate. J Chromatogr A (2010) 0.80
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia. Anticancer Drugs (1997) 0.80
Biological characterization of subgroups of squamous cell lung carcinomas. Clin Cancer Res (1999) 0.80
Reversal of doxorubicin-resistance in solid tumors by clomipramine. In Vivo (1995) 0.80
Different growth rates of lung tumours in man and their xenografts in nude mice. Eur J Cancer (1980) 0.80
Rapid screening of macromolecular synthesis in single cell cultures. Naturwissenschaften (1968) 0.79
Interleukin-8 receptors in normal and psoriatic polymorphonuclear leukocytes. Acta Derm Venereol (1992) 0.79
Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts. In Vivo (1992) 0.79
Reduced binding of carcinogenic hydrocarbons to DNA of mouse skin during inhibition of DNA synthesis. Nature (1968) 0.79
[Sensitivity tests of human malignant tumors to cytostatic drugs]. Klin Wochenschr (1971) 0.79
Expression of heat shock proteins, glutathione peroxidase and catalase in childhood acute lymphoblastic leukemia and nephroblastoma. Cancer Lett (1996) 0.79
Growth kinetics of human lung tumours in nude mice. Exp Cell Biol (1981) 0.79
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results. Arch Geschwulstforsch (1974) 0.79
Microvessel density and vascular endothelial growth factor expression in human tumors of different localization. Oncol Rep (1996) 0.79
Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann Hematol (1994) 0.79
Liver as a tumor cell killing organ: Kupffer cells and natural killers. Cancer Res (1986) 0.79
Kupffer cells recognize trinitrobenzene-labeled erythrocytes. Immunol Lett (1982) 0.79
In-vitro testing of cyclophosphamide on tumors. Naturwissenschaften (1975) 0.79
nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.79
Albumin messenger RNA after partial hepatectomy and sham operation. Biochim Biophys Acta (1980) 0.78
Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL). Anticancer Res (1998) 0.78
Flow cytometric analysis of primary lung carcinomas and their lymph node metastases. Anticancer Res (1987) 0.78
Differential expression of intermediate-filament proteins in murine sarcoma 180 ascites or solid tumor. Cancer Res (1984) 0.78
Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer. Cancer Lett (1996) 0.78
[Sensitivity testing of malignant human tumors against cytostatic agents. II]. Klin Wochenschr (1972) 0.78
Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia. Cancer Lett (1995) 0.78
Apoptotic index, Fas and bcl-2 in initial and relapsed childhood acute lymphoblastic leukaemia. Apoptosis (1997) 0.78
Influence of hormone therapy on human lung tumors transplanted into nude mice. Oncology (1985) 0.78
Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines. Anticancer Drugs (1997) 0.78
Vascular liver tumors induced in Mastomys (Praomys) natalensis by single or twofold administration of dimethylnitrosamine. J Natl Cancer Inst (1979) 0.78
Taxanes in adjuvant and neoadjuvant therapies for breast cancer. Oncology (Williston Park) (1998) 0.78
Changes in the concentrations of elements in liver after partial hepatectomy. Experientia (1974) 0.78
Predicting chemosensitivity of tumors. Breast Cancer Res Treat (1986) 0.78
[Prognostic significance of flow cytophotometric studies in ovarian cancer]. Geburtshilfe Frauenheilkd (1987) 0.78
[Rapid determination of DNA synthesis with 3H-thymidne]. Naturwissenschaften (1968) 0.77
Modulation of doxorubicin-toxicity by tamoxifen in multidrug-resistant tumor cells in vitro and in vivo. J Cancer Res Clin Oncol (1994) 0.77
Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788. Anticancer Res (1993) 0.77
Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells. Oncology (1993) 0.77
High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue. Eur J Cancer (1993) 0.77